| Title: |
An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2 |
| Authors: |
Demaegd, Koen C.; Kernan,Aoife; Cooper-Knock,Johnathan; van Vugt, Joke J.F.A.; Harvey,Calum; Moll,Tobias; O’Brien,David; Gornall,Sarah; Drury,Luke; Farhan,Sali M.K.; Dion,Patrick A.; Rouleau,Guy A.; Western,Andrea; Parsons,Paul J.; Mclean,Benjamin; Benatar,Michael; van den Berg, Leonard H.; Van Damme,Philip; Willem Dankbaar, Jan; Hendrikse, Jeroen; Koole, Wouter; de Bie, Charlotte; Hobson,Esther; Veldink, Jan H.; van de Warrenburg,Bart; Pasterkamp, R. Jeroen; van Rheenen, Wouter; Kirby,Janine; Shaw,Pamela J.; van Es, Michael A.; Opleiding Neurologie; Brain; Neurogenetica; Neurologen; Projectafdeling ALS; MS Radiologie; Cancer; Circulatory Health; Divisie Beeld & Oncologie; Genetica; Genetica Sectie Genoomdiagnostiek; Genetica Klinische Genetica; Genetic Risks; Translational Neuroscience; Regenerative Medicine and Stem Cells; Neuromuscular Disorders |
| Publication Year: |
2025 |
| Subject Terms: |
Genetics; Genetics(clinical) |
| Description: |
Spinocerebellar ataxia type 2 (SCA2) and amyotrophic lateral sclerosis (ALS) are both associated with a CAG-repeat expansion in ATXN2 and with TDP-43-positive neuronal cytoplasmic inclusions. The two disorders have been viewed as distinct entities, where an intermediate length expansion of 31-33 CAG-repeats is associated with sporadic ALS and a full length expansion of ≥34 CAG-repeats is associated with SCA2. We report the clinical phenotype of ATXN2-positive patients and their relatives, identified in three specialist ALS clinics, which force a reconsideration of this dichotomy. We also report the frequency of ATXN2 expansions in two large cohorts of ALS patients and in a population-matched cohort of controls. We report ten cases of familial ALS in which disease is associated with either an intermediate or a full-length ATXN2 CAG-repeat expansion. Pedigrees and patients feature additional phenotypes including parkinsonism, dementia and essential tremor (ET). We conclude that CAG-repeat expansions in ATXN2 exhibit pleiotropy and are associated with a disease spectrum that includes ALS, SCA2, and parkinsonism; to recognise this complexity we propose the new term ‘ATXN2-related neurodegeneration’. We also observed sporadic ALS associated with full-length expansions. We conclude that ATXN2 CAG-repeat expansions, irrespective of length, should be considered a risk factor for ALS. Interrupted CAG-repeats were associated with an ALS phenotype in our data but we also identified ALS cases with uninterrupted expansions. Our findings have relevance for researchers, patients and families linked to CAG-repeat expansions in ATXN2. |
| Document Type: |
article in journal/newspaper |
| File Description: |
application/pdf |
| Language: |
English |
| ISSN: |
1018-4813 |
| Relation: |
https://dspace.library.uu.nl/handle/1874/465532 |
| Availability: |
https://dspace.library.uu.nl/handle/1874/465532 |
| Rights: |
info:eu-repo/semantics/OpenAccess |
| Accession Number: |
edsbas.423F99F4 |
| Database: |
BASE |